1. Home
  2. RVPH vs LSBK Comparison

RVPH vs LSBK Comparison

Compare RVPH & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • LSBK
  • Stock Information
  • Founded
  • RVPH 2006
  • LSBK 1891
  • Country
  • RVPH United States
  • LSBK United States
  • Employees
  • RVPH N/A
  • LSBK N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • LSBK Savings Institutions
  • Sector
  • RVPH Health Care
  • LSBK Finance
  • Exchange
  • RVPH Nasdaq
  • LSBK Nasdaq
  • Market Cap
  • RVPH 88.0M
  • LSBK 91.1M
  • IPO Year
  • RVPH N/A
  • LSBK 2006
  • Fundamental
  • Price
  • RVPH $1.80
  • LSBK $15.80
  • Analyst Decision
  • RVPH Strong Buy
  • LSBK
  • Analyst Count
  • RVPH 5
  • LSBK 0
  • Target Price
  • RVPH $11.40
  • LSBK N/A
  • AVG Volume (30 Days)
  • RVPH 1.6M
  • LSBK 4.1K
  • Earning Date
  • RVPH 11-14-2024
  • LSBK 01-24-2025
  • Dividend Yield
  • RVPH N/A
  • LSBK 4.56%
  • EPS Growth
  • RVPH N/A
  • LSBK 7.32
  • EPS
  • RVPH N/A
  • LSBK 0.88
  • Revenue
  • RVPH N/A
  • LSBK $25,846,000.00
  • Revenue This Year
  • RVPH N/A
  • LSBK N/A
  • Revenue Next Year
  • RVPH N/A
  • LSBK N/A
  • P/E Ratio
  • RVPH N/A
  • LSBK $17.95
  • Revenue Growth
  • RVPH N/A
  • LSBK N/A
  • 52 Week Low
  • RVPH $0.60
  • LSBK $10.30
  • 52 Week High
  • RVPH $4.50
  • LSBK $16.56
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 45.36
  • LSBK 64.39
  • Support Level
  • RVPH $1.97
  • LSBK $15.51
  • Resistance Level
  • RVPH $2.14
  • LSBK $16.56
  • Average True Range (ATR)
  • RVPH 0.16
  • LSBK 0.42
  • MACD
  • RVPH -0.02
  • LSBK 0.08
  • Stochastic Oscillator
  • RVPH 29.29
  • LSBK 75.95

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

Share on Social Networks: